The high cost of patient care is influencing many decisions in today’s healthcare marketplace. The expense of treating ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
November 14, 2007 - The European peripheral stents market is in the developmental phase, both in terms of revenue and ...
A clot that forms in the deep vein in either the leg or pelvic region is known as a deep vein thrombosis (DVT), an ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
November 13, 2007 — Arterial Remodeling Technologies (ART) will receive $7.8 million from investors to pursue CE Mark ...
November 13, 2007 - Stereotaxis Inc. announced the first atrial fibrillation procedures performed with its partnered ...
Concentric Medical has obtained FDA 510(k) clearance for its Merci L6 Retriever, a device that restores blood ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
AGA Medical Corp. announced today that it has received FDA and European CE Mark approvals for the AMPLATZER ...
Cordis Corp. announced the introduction in the U.S. market of the FIRE STAR Rx PTCA Dilatation Catheter and the DURA ...
November 4, 2007 – A patient care program in North Carolina shortened the time it took to treat heart attack patients ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
November 4, 2007 - Itamar Medical announced that four presentations at AHA, including one from the Framingham Heart ...
November 5, 2007 - A pooled analysis of the E-SIRIUS and C-SIRIUS trials, called New SIRIUS, found that the CYPHER ...
November 5, 2007 – Boston Scientific Corp. highlighted at the American Heart Association conference its new Stentplus ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
November 4, 2007 – The antiplatelet drug prasugrel offered greater benefit than current, standard therapy for patients ...
November 4, 2007 – A specific way of dosing eptifibatide appears equally effective as giving abciximab as an adjunct to ...
November 4, 2007 – Drug-eluting stents to open blocked coronary arteries caused no more risks for death or heart ...